GlassScriptPhysician profile
Payam Rohani
NPI 1801029921
$1,370.60
in general payments reported to CMS, 2019-2025
10 companies · $587 in 2025
The $587 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.98 · 2020: $56.57 · 2021: $17.58 · 2022: $65.13 · 2023: $126 · 2024: $469 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Education: $53.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.34 |
| Education | $53.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.58 | 2022-2025 | Dalvance, Teflaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $249.65 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $190.75 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.71 | 2020-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $102.69 | 2019-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $85.76 | 2025 | Zerbaxa |
| Novartis Pharmaceuticals Corporation | $85.06 | 2019-2024 | |
| Pfizer INC. | $50.63 | 2025 | |
| Scpharmaceuticals INC. | $23.94 | 2024 | |
| Daiichi Sankyo INC. | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payam Rohani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.